There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on SELLAS Life Sciences Group (SLS – Research Report) and Vaccitech Plc (VACC – Research Report) with bullish sentiments. SELLAS Life Sciences Group (SLS) Maxim Group analyst Jason McCarthy maintained a Buy rating on SELLAS Life Sciences Group yesterday and set a price target of $12.00. The company's shares closed last Tuesday at $2.93, close to its 52-week low of $2.10. According to TipRanks.
https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-151?utm_source=advfn.com&utm_medium=referral
Vaccitech (NASDAQ:VACC)
Historical Stock Chart
From May 2022 to Jun 2022 Click Here for more Vaccitech Charts.
Vaccitech (NASDAQ:VACC)
Historical Stock Chart
From Jun 2021 to Jun 2022 Click Here for more Vaccitech Charts.